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1. Introduction 
A large portion of the (Y chain could be iso- 
lated from cyanogen bromide (CNBr) cleaved 
bovine fibrinogen in the peptide F-CB3 which 
contains a single disulfide bridge [l] . Biochemical 
[2,3] and immunological [4,5] evidence indicated 
that large parts of the F-CB3 moiety should be 
located on the surface of the intact fibrinogen mol- 
ecule. This agrees with previous observations (re, 
viewed in [6] ) on a particular lability of the cy chain 
during degradation of fibrinogen by plasmin. Charac- 
terization of structural and immunological prbperties 
of F-CB3 may therefore aid in a better understanding 
of the process of fibrinolysis. 
The present study describes the isolation of 
peptide F-CB3 from human fibrinogen which is 
similar in structure but not in antigenicity to the 
previously reported bovine counterpart. A radio- 
immune assay and other serological methods dem- 
onstrated lack of cross-reaction with fragments D 
and E known to be the stable end products of 
plasmic degradation. 
2. Experimental 
Human fibrinogen was obtained from Kabi AB, 
Stockholm, and purified to 97% clottability by 
established procedures [7,8]. Cleavage by CNBr and 
purification of peptide F-CB3 followed essentially 
the methods described for bovine fibrinogen [ 11. 
Reduction and alkylation was carried out as de- 
scribed [9]. The constituent chains of human 
fibrinogen were isolated by CM-cellulose chro- 
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matography [lo] . Plasmic fragments D and E and 
respective rabbit antisera were a gift of Dr H. 
Karges, Behringwerke, Marburg. Amino acid 
composition was determined as described previously 
[9] on a Durrum D 500 analyzer. The tryptophan 
content was measured on the amino acid analyzer 
after hydrolysis with methane-sulfonic acid [ 1 l] . 
Polyacrylamide gel electrophoresis in presence of 
sodium dodecyl sulfate (SDS) [ 121 was used for 
molecular weight determination utilizing reduced 
and alkylated globular proteins for calibration [ 11. 
Three rabbits were immunized with human F-CB3 
by a schedule used previously for fibrinogen [4]. 
Gel precipitation and passive hemagglutination was 
done according to standard procedures and details 
have been described elsewhere [4,9] . Labeling of 
human F-CB3 with 12’1 titration of antisera in a 
radioimmune assay and inhibition tests were the 
same as described for bovine F-CB3 [5] except that 
the immune complexes were precipitated with 40% 
saturated ammonium sulfate [ 131 instead of with a 
goat antiserum to rabbit IgG. Results were calcu- 
lated as suggested by Minden and Farr [ 131. 
3. Results 
Recently three large CNBr peptides, F-CBl, F-CB2 
and F-CB3, could be isolated and characterized from 
bovine fibrinogen [l] . Comparison of CNBr cleaved 
human and bovine fibrinogen by SDS disc electro- 
phoresis showed the same three major bands (fig.1) 
which, however, had a slightly higher mobility in 
case of the human preparations. Purification of 
F-CB3 was achieved by initial chromatography on 
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Fig.1. Disc electrophoresis pattern of CNBr digested human 
(H) and bovine (B) fibrinogen, of the purified human 
peptide F-CB3 in its native (nr) and reduced (r) form. 
Positions of individual CNBr peptides from bovine 
fibrinogen [ I] are indicated on the left hand side. Anode at 
the bottem. 
Sephadex G-100 (fig.2). The rear portion of the 
peak containing F-CB3 and some F-CB2 was 
rechromatographed on Sephadex G-200 at pH 8.6 
[ 1] or on Bio-Gel P.60 in 0.2 M formic acid. The 
final preparation of F-CBS was then pure as judged 
Fig.2. Separation of 450 mg CNBr peptides of human 
fibrinogen on Sephadex GlOO. The column (5 X 76 cm) 
was eluted with 0.2 M ammonium formate pH 2.5. The pool 
used for further purification of F-CB3 is indicated on the 
base line as a horizontal bar. 
by electrophoresis (fig.1). The amino acid composi- 
tion of the peptide, given in table 1, revealed charac- 
teristic features found previously for bovine F-CB3 
[4] like a high content of glycine, serine and threo- 
nine and low tyrosine values. Human F-CB3 also 
contained two half cystine residues, between one 
and two homoserine residues and small amounts of 
methionine. 
Electrophoretic properties of F-CB3 were not 
changed after reduction and alkylation (fig.1). A 
mol. wt of29 700 + 1000 could be determined for 
reduced F-CB3 by SDS disc electrophoresis. Chroma- 
tography of the reduced peptide on Bio-Gel P-l 0 in 
0.2 M ammonium bicarbonate pH 8.6 revealed a 
single peak, emerging with the void volume which 
contained more than 99% of the material recovered 
Table 1 
Amino acid composition of peptide F-CB3 from human 
fibrinogen a 
--._l_ll--__-.___--. .--.-.___ .- 
Native peptide Reduced peptide 
---_- 
Half cystine 
Aspartic acid 
Threonine 
Serine 
Momoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Pilenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
2 (1.6) 
2.5 
37 
56 
l(1.5) 
27 
20 
49 
8 (7.9) 
11 
1 (0.5) 
4 (3.8) 
5 (5.4) 
3 (3.0) 
3 (2.8) 
5 (4.9) 
12 
15 
7 (7.4) 
2 (2.l)b 
23 
34 
61 
l(1.4) 
28 
18 
49 
10 
10 
1 (0.8) 
4 (3.8) 
6 (5.7) 
3 (3.3) 
3 (2.8) 
5 (5.0) 
11 
15 
n.d.c 
Total 
-~-- 
291 284 
__I_-._ 
Given as residues per mole peptide assuming a mol. wt of 
29 700. Values are rounded off to the nearest whoie 
number, actual values are given in brackets for iess than 
10 residues. Values for threonine and serine are corrected 
by factors 1.12 and 1.25, respectively 191. Average 
values from 4 to 6 different preparations. 
As carboxy~nethyl cysteine. 
Not determined. 
270 
Volume 58, number 1 E'EBSLETTERS October 1975 
I I I I I I I I I I I I 
amount of Inhibitor [pmole] 
Fig.3. Inhibition of binding of ‘251-labeled human F-CB3 to antibodies against F-CB3 by different antigens. Inhibitors used were 
human F-CB3 (X-X), human fibrinogen (o-o) and its constituent a(~--a), P(*-0) and y chain (V--T), reduced and 
alkylated human F-CB3 (o--o), human plasmic fragments D (v-0) and E (A--A) and bovine F-CB3 (m-w). 
from the column (data not shown). Amino acid 
composition of the peptide contained in this peak 
resembled closely that of native F-CB3 (table 1) 
also with respect to the cysteine, homoserine and 
methionine content. 
Rabbit antisera to human F-CB3 did strongly 
bind ‘251-labeled human F-CB3 in a manner as was 
observed for the corresponding bovine system [5]. 
Inhibition assays which are shown in fig.3 were used 
to study the relationship to other antigenic fragments. 
No differences were observed when comparing 
native and reduced F-CB3. Native fibrinogen and its 
constituent (II chain were also strong inhibitors 
except that 3-fold higher amounts were required to 
obtain the same effect as with F-CB3. Even though 
this difference is apparently close to the experimen- 
tal error in this assay, it may still reflect a slight 
change in antigenic structure. The /3 chain was a lOO- 
fold less potent inhibitor compared to the (Y chain 
whereas y chain did not have any activity. Lack of 
inhibitory activity was also indicated for plasmin 
fragments D and E from human fibrinogen and for 
the bovine peptide F-CB3. Inhibitory effects observed 
for the fl chain and with fragments D and E at very 
high concentrations are probably due to contamina- 
tion by traces of 01 chains and larger plasmic frag- 
ments, respectively, which cannot be detected by 
usual biochemical methods. 
The relation between F-CB3 and fragments D and 
E was also studied by gel precipitation and passive 
hemagglutination (data not shown). Both tests 
revealed a strong reaction between rabbit antibodies 
to fragments D and E and the antigen used for 
immunization and no or negligible reactions with 
F-CB3. Antibodies to F-CB3 showed high aggluti- 
nation titers (range 1: 256 to 1: 1024) for F-CB3 but 
no cross reaction was observed with fragments D and 
E. Only faint reactions were found with F-CB3 in 
gel diffusion tests. 
4. Discussion 
Amino acid composition and immunological evi- 
dence for an exclucive relation to the (Y chain indi- 
cate that the CNBr peptide from human fibrinogen 
which has been characterized in the present study is 
homologous to the previously described peptide 
F-CB3 from bovine fibrinogen [ 1,4] . The sum of 
methionine and homoserine accounts for two 
residues in human F-CB3. Presumably, the chain 
contains an uncleaved methionine which may be 
partly converted to a component giving rise to homo- 
serine upon acid hydrolysis [ 141. Support for this 
interpretation was obtained by reduction experiments 
which failed to demonstrate a large change in size 
and the existence of a disulfide-bonded small peptide 
entity. Thus, human and bovine F-CB3 have basic- 
ally the same single chain structure which is folded 
into a loop by one disulfide bridge. However, the 
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human peptide is smaller by about 6000 daltons. Acknowledgments 
Lack of cross-reactivity between human and 
bovine F-CB3 was corroborated by identical findings 
with antibodies to the bovine peptide [5]. Both 
antigens are identical with respect to a complete 
cross-reaction observed for homologous fibrinogen 
and reduced F-CB3. The weak activity of human 
F-CB3 in gel precipitation contrasts with a strong 
reaction in other serological tests and may be due to 
the existence of just one or a few antigenic determi- 
nants on the peptide. The antigenic structure of 
bovine F-CB3 is apparently more complex [5]. 
The constituent chains of human fibrinogen were 
generously supplied by Dr A. Hens&en. We further 
wish to acknowledge the expert technical assistance 
of Mr C. de Lorenzo and the financial support by 
grants of the Deutsche Forschungsgemeinschaft, SFB 
51 and project Ti 95/l. 
Several immunological methods failed to show any 
relation between F-CB3 and plasmin fragments D 
and E. Observations on a localization of fragment D 
close to the amino-terminal fragment E [ 151 suggests 
that the F-CB3 moiety should originate from the 
C-terminal portion of CY chain. In fact, a recent study 
of Hessel [ 161 indicated the release of an cy chain 
fragment with a mol. wt of 50 000 in early phases of 
plasmic digestion. Upon further cleavage with 
CNBr a fragment was obtained which resembled 
peptide F-CB3 in size and amino acid composition. 
Thus, the sensitive radioimmune inhibition assay 
described for F-CB3 should be useful for charac- 
terizing early products of fibrinolysis in human 
serum under normal and clinical conditions. Since 
tryptic cleavage of bovine F-CB3 did not abolish 
serologic activity [ 51 one may expect applications 
even in cases where extensive plasmic degradation 
has occurred. 
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